Sherwood J B, Goldwasser E
Endocrinology. 1976 Aug;99(2):504-10. doi: 10.1210/endo-99-2-504.
Cells from human renal tumors were grown in monolayer cultures, and the media obtained at each medium change were assayed for erythropoietin activity. The medium from carcinoma I (a granular cell tumor) contained a high level of activity initially. The concentration of erythropoietin activity decreased with time in culture, but was significantly higher than that in controls after four months in vitro. There was , in addition, evidence of an inhibitory material present in the culture media. The activity formed by the tumor cells could be neutralized by an antibody to human urinary erythropoietin. The difference between activity measured in marrow cell cultures and that found by in vitro assay, and the chromatographic properties of the active preparation, suggest that the tumor-derived activity may be largely asialoerthropoietin. Two other renal carcinomas, of a different cellular type, produced significant erythropoietic activity.
将人肾肿瘤细胞进行单层培养,每次更换培养基时收集的培养基均用于检测促红细胞生成素活性。来自癌 I(颗粒细胞瘤)的培养基最初含有高水平的活性。促红细胞生成素活性浓度随培养时间下降,但在体外培养四个月后仍显著高于对照组。此外,有证据表明培养基中存在一种抑制物质。肿瘤细胞产生的活性可被抗人尿促红细胞生成素抗体中和。骨髓细胞培养中测得的活性与体外测定结果的差异以及活性制剂的色谱特性表明,肿瘤衍生的活性可能主要是脱唾液酸促红细胞生成素。另外两种不同细胞类型的肾癌也产生了显著的促红细胞生成活性。